<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03023475</url>
  </required_header>
  <id_info>
    <org_study_id>VesselHarvestingLigaSure</org_study_id>
    <nct_id>NCT03023475</nct_id>
  </id_info>
  <brief_title>Comparison of Two Different Endoscopic Radial Artery Harvesting Devices</brief_title>
  <official_title>Prospective Randomized Comparison of Two Different Endoscopic Radial Artery Harvesting Devices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kerckhoff Klinik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kerckhoff Klinik</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endoscopic radial artery harvesting in coronary bypass surgery is routinely performed by the
      investigators. In this study, the investigators want to compare the MiFusion TLS2 (Endotrust
      GmbH, Germany) device to the LigaSure Maryland Jaw (Medtronic, USA). The vessel harvesting is
      performed in the standard fashion according to the institutional routine. The patients are
      randomized preoperatively to one of the devices. The proximal end of the radial artery will
      be preserved and deep-frozen for histological assessment. Endothelial integrity will be
      investigated using Hematoxylin-Eosin, CD31 and endothelial nitrogen monoxide synthase.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial integrity of the radial artery using histological examination.</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Harvesting time</measure>
    <time_frame>The harvesting time will be measured during the vessel harvesting surgery.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemostasis in the arm indicated by bleeding from radial artery side branches or veins in the arm.</measure>
    <time_frame>Intraoperatively and directly after vessel harvesting the arm is controlled using the endoscope and bleeding can be detected during this control. End of surgery is end of this outcome parameter.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of vessel sealing, if side branches of the radial artery are bleeding after blood insufflation, additional clips have to placed at the side branch.</measure>
    <time_frame>The blood insufflation is performed immediately after vessel harvesting and leaks can be detected.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>CABG Graft Integrity</condition>
  <arm_group>
    <arm_group_label>LigaSure endoscopic radial harvesting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The endoscopic vessel harvesting will be performed using the LigaSure device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TLS2 endoscopic radial harvesting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The endoscopic vessel harvesting will be performed using the TLS2 device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LigaSure endoscopic vessel harvesting</intervention_name>
    <description>The radial artery will be harvested endoscopically using the LigaSure system.</description>
    <arm_group_label>LigaSure endoscopic radial harvesting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TLS2 endoscopic vessel harvesting</intervention_name>
    <description>The radial artery will be harvested endoscopically using the TLS2 system.</description>
    <arm_group_label>TLS2 endoscopic radial harvesting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all adult patients undergoing CABG using the radial artery

          -  capability to give informed consent

        Exclusion Criteria:

          -  no specific exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud Van Linden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kerckhoff Klinik</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arnaud Van Linden, MD</last_name>
    <phone>+49 6032 9966153</phone>
    <email>avanlinden@icloud.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Walther, PhD</last_name>
    <phone>+4960329962502</phone>
    <email>t.walther@kerckhoff-klinik.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kerckhoff Klinik</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2017</study_first_submitted>
  <study_first_submitted_qc>January 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2017</study_first_posted>
  <last_update_submitted>January 17, 2017</last_update_submitted>
  <last_update_submitted_qc>January 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

